lisdexamfetamine dimesilate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle AUST R: 284019Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
14 Jun 2024
to
21 Aug 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling the supply. The sponsor is working to expedite the next shipment.
|
VYVANSE lisdexamfetamine dimesilate 60 mg capsules bottle AUST R: 284021Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
30 Aug 2024
to
21 Oct 2024
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is closely controlling the supply. The sponsor is working to expedite the next shipment.
|
VYVANSE lisdexamfetamine dimesilate 40 mg capsules bottle AUST R: 284020Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
22 Jan 2024
to
30 Apr 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|